RIGI and infection: The dose-dependent bi-specificity of miR-485 for both RIG-I (Figure 1) and H5N1 PB1 revealed that endogenous miR-485 targets RIG-I mRNA in HEK 293T cells infected at a lower multiplicity of infection (MOI), which leads to the suppression of antiviral response (Table 1).